124 related articles for article (PubMed ID: 8779043)
1. [Hemolysis during immunoglobulin therapy].
Muñoz J; García A; Jordán C; Rubió A; Ferrán C; Martínez Matos JA
Sangre (Barc); 1996 Feb; 41(1):72-3. PubMed ID: 8779043
[No Abstract] [Full Text] [Related]
2. Massive intravascular haemolysis after high dose intravenous immunoglobulin therapy.
Mohamed M; Bates G; Eastley B
Br J Haematol; 2013 Mar; 160(5):570. PubMed ID: 23294261
[No Abstract] [Full Text] [Related]
3. Specifications for anti-A and anti-B in intravenous immunoglobulin: history and rationale.
Thorpe SJ
Transfusion; 2015 Jul; 55 Suppl 2():S80-5. PubMed ID: 26174902
[TBL] [Abstract][Full Text] [Related]
4. ABO-immunoglobulin G antibodies in intravenous immune globulin can interfere in ABO-mismatched kidney transplants.
Boctor FN; Bhaskaran M; Sheahan B; Heaton WA; Molmenti E
Transfusion; 2011 Aug; 51(8):1874-5. PubMed ID: 21831188
[No Abstract] [Full Text] [Related]
5. Acute hemolysis in a patient with cytomegalovirus pneumonitis treated with intravenous immunoglobulin (IVIG).
Coghill J; Comeau T; Shea T; Braddy L; Bandarenko N; Afenyi-Annan A; Harvey D
Biol Blood Marrow Transplant; 2006 Jul; 12(7):786-8. PubMed ID: 16785068
[No Abstract] [Full Text] [Related]
6. Therapeutic plasma exchange as a therapeutic modality for the treatment of IVIG complications.
Welsh KJ; Bai Y
J Clin Apher; 2015 Dec; 30(6):371-4. PubMed ID: 26123478
[TBL] [Abstract][Full Text] [Related]
7. Anti-A and anti-B: what are they and where do they come from?
Branch DR
Transfusion; 2015 Jul; 55 Suppl 2():S74-9. PubMed ID: 26174901
[TBL] [Abstract][Full Text] [Related]
8. ABO zygosity, but not secretor or Fc receptor status, is a significant risk factor for IVIG-associated hemolysis.
Branch DR; Hellberg Å; Bruggeman CW; Storry JR; Sakac D; Blacquiere M; Tong TN; Burke-Murphy E; Binnington B; Parmar N; Riden LS; Willie K; Armali C; Aziz J; Lieberman L; Laroche V; Callum J; Lin Y; Shehata N; Pavenski K; Lau W; Hannach B; Kuijpers TW; Olsson ML; Cserti-Gazdewich C; Pendergrast J
Blood; 2018 Feb; 131(7):830-835. PubMed ID: 29305554
[No Abstract] [Full Text] [Related]
9. The evaluation of graft irradiation as a method of preventing hemolysis after ABO-mismatched renal transplantation.
Ishida H; Tanabe K; Tokumoto T; Shimmura H; Toma H
Transpl Int; 2002 Sep; 15(8):421-4. PubMed ID: 12221462
[TBL] [Abstract][Full Text] [Related]
10. [Massive hemolysis following allogeneic peripheral blood stem cell transplantation with minor ABO incompatibility].
Ishiyama M; Iwabe K; Hida M; Okamura T; Yoshinaga K; Hidai H; Kobayashi S; Sameshima Y; Mori N; Teramura M; Masuda M; Motoji T; Mizoguchi H
Rinsho Ketsueki; 2002 Jun; 43(6):477-81. PubMed ID: 12134705
[TBL] [Abstract][Full Text] [Related]
11. Addressing hemolysis in an infant due to mother-infant ABO blood incompatibility.
Martin S; Jerome RN; Epelbaum MI; Williams AM; Walsh W
J Med Libr Assoc; 2008 Jul; 96(3):183-8. PubMed ID: 18654647
[No Abstract] [Full Text] [Related]
12. Therapeutic strategies in management of the highly HLA-sensitized and ABO-incompatible transplant recipients.
Jordan SC; Peng A; Vo AA
Contrib Nephrol; 2009; 162():13-26. PubMed ID: 19001810
[TBL] [Abstract][Full Text] [Related]
13. Early and fatal immune haemolysis after so-called 'minor' ABO-incompatible peripheral blood stem cell allotransplantation.
Oziel-Taieb S; Faucher-Barbey C; Chabannon C; Ladaique P; Saux P; Gouin F; Gastaut JA; Maraninchi D; Blaise D
Bone Marrow Transplant; 1997 Jun; 19(11):1155-6. PubMed ID: 9193761
[TBL] [Abstract][Full Text] [Related]
14. Compatibility problems after intravenous immunoglobulin--a case report.
Sulochana PV; Mathai J; Sathyabhama S; Augustine P
Indian J Pathol Microbiol; 1998 Oct; 41(4):495-8. PubMed ID: 9866917
[TBL] [Abstract][Full Text] [Related]
15. Nonfatal intravascular hemolysis in a pediatric patient after transfusion of a platelet unit with high-titer anti-A.
Harris SB; Josephson CD; Kost CB; Hillyer CD
Transfusion; 2007 Aug; 47(8):1412-7. PubMed ID: 17655585
[TBL] [Abstract][Full Text] [Related]
16. Repeat ABO-incompatible platelet transfusions leading to haemolytic transfusion reaction.
Sadani DT; Urbaniak SJ; Bruce M; Tighe JE
Transfus Med; 2006 Oct; 16(5):375-9. PubMed ID: 16999762
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic red blood cell exchange for prevention of severe immune hemolysis in minor ABO-mismatched allogeneic peripheral blood progenitor cell transplantation after reduced-intensity conditioning.
Worel N; Greinix HT; Supper V; Leitner G; Mitterbauer M; Rabitsch W; Fischer G; Rosenmayr A; Höcker P; Kalhs P
Transfusion; 2007 Aug; 47(8):1494-502. PubMed ID: 17655594
[TBL] [Abstract][Full Text] [Related]
18. Transmission of an anti-RhD alloantibody from donor to recipient after ABO-incompatible BMT.
Franchini M; de Gironcoli M; Gandini G; Vassanelli A; Rocca P; Benedetti F; Aprili G
Bone Marrow Transplant; 1998 May; 21(10):1071-3. PubMed ID: 9632284
[TBL] [Abstract][Full Text] [Related]
19. Hemolysis from platelet transfusion: call to action for an underreported reaction.
Quillen K
Transfusion; 2012 Oct; 52(10):2072-4. PubMed ID: 23110729
[No Abstract] [Full Text] [Related]
20. Failure to predict hemolysis and hyperbilirubinemia by IgG subclass in blood group A or B infants born to group O mothers.
Kaplan M; Na'amad M; Kenan A; Rudensky B; Hammerman C; Vreman HJ; Wong RJ; Stevenson DK
Pediatrics; 2009 Jan; 123(1):e132-7. PubMed ID: 19114458
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
